KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Shareholding for the Period Ended December 31, 2021
Kothari Fermentation & Biochem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Disclosure Under Regulation-30
This is to inform you that Kothari Fermentation and Biochem Limited is in the process of launching its new product Yeast Extract Powder and Mono Oligo Saccharides (Mannan and Beta Glucan). This product is mainly used in Pharmaceutical sector and also suitable for food and food stuff, dietary foods, beverages, soups, seasonings, low calorie food, Nutritional filler, Microbial growth media, Fermentation substrate Biotech, Biotech Research, etc. The Company has done forward integration of value added product and established the new Yeast Extract Power plant having the production capacity of 150 MT per month and 100 MT of Mono Oligo Saccharides (cell wall) Per month, in its factory situated at Sikandrabad, Distt. Bulandshahr, Uttar Pradesh. KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Clarification sought from Kothari Fermentation & Biochem Ltd
The Exchange has sought clarification from Kothari Fermentation & Biochem Ltd on January 12, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the Certificate received from M/s Abhipra Capital Limited, the Registrar and share Transfer Agent of the Company, for the quarter ended December 31, 2021. KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- KAVITA TANWARDesignation :- Company Secretary and Compliance Officer KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Closure of Trading Window
This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct for regulating, monitoring and reporting of trading by Insiders, the Trading Window for dealing in the Equity Shares of the company by Designated Persons, is closed from January 1, 2022 upto the completion of 48 hours after the declaration of the Unaudited Financial Results of the company for the quarter ended December 31, 2021. KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 11, 2021 for Pramod Kumar Kothari (HUF) KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Board Meeting Outcome for Revised Outcome
Revised outcome Kothari Fermentation & Biochem Ltd - 507474 - Related Party Transaction Disclosure
Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find herewith enclosed the Related Party Transaction Disclosure for the half year ended 30th September, 2021. KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 13th November, 2021 considered and approved, interalia, the Unaudited Financial Results along with Limited Review Report of the Company for the quarter and half year ended on 30th September, 2021.